Anti-angiogenic therapy of proliferative diabetic retinopathy

Author： Danis R.P.   Ciulla T.A.   Criswell M.   Pratt L.  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.3, 2001-03, pp. : 395-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rhinitis and epistaxis in patients treated by anti-angiogenic therapy

By Prulière-Escabasse V.   Escudier E.   Balheda R.   Soria J.   Coste A.   Massard C.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 285-286

Springer Publishing Company

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic and Anti-Inflammatory Effects of Statins: Relevance to Anti-Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 579-594

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic therapy for diabetic retinopathy

By Speicher Matthew A   Danis Ronald P   Criswell Mark   Pratt Linda  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite